These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 37880853)
1. Genomic instability-associated two-miRNA signature as a novel prognostic biomarker in breast cancer. Zhang Y; Chen Y; Liu T J Gene Med; 2024 Jan; 26(1):e3604. PubMed ID: 37880853 [TBL] [Abstract][Full Text] [Related]
2. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer. Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002 [TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693 [TBL] [Abstract][Full Text] [Related]
4. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder. Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881 [TBL] [Abstract][Full Text] [Related]
5. Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Volinia S; Croce CM Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7413-7. PubMed ID: 23589849 [TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
7. Identifying a new microRNA signature as a prognostic biomarker in colon cancer. Lv Y; Duanmu J; Fu X; Li T; Jiang Q PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961 [TBL] [Abstract][Full Text] [Related]
8. A Novel TCGA-Validated, MiRNA-Based Signature for Prediction of Breast Cancer Prognosis and Survival. Tian B; Hou M; Zhou K; Qiu X; Du Y; Gu Y; Yin X; Wang J Front Cell Dev Biol; 2021; 9():717462. PubMed ID: 34589485 [TBL] [Abstract][Full Text] [Related]
9. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues. Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314 [TBL] [Abstract][Full Text] [Related]
10. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes. Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas. Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839 [TBL] [Abstract][Full Text] [Related]
12. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer. Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020 [TBL] [Abstract][Full Text] [Related]
13. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis. Zheng L; Wang J; Jiang H; Dong H Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer. Lai J; Chen B; Zhang G; Wang Y; Mok H; Wen L; Pan Z; Su F; Liao N Aging (Albany NY); 2019 Sep; 11(18):7525-7536. PubMed ID: 31548433 [TBL] [Abstract][Full Text] [Related]
15. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance. Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945 [TBL] [Abstract][Full Text] [Related]
16. Development of a 7-miRNA prognostic signature for patients with bladder cancer. Xv Y; Qiu M; Liu Z; Xiao M; Wang F Aging (Albany NY); 2022 Dec; 14(24):10093-10106. PubMed ID: 36566019 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma. Xie M; Lv Y; Liu Z; Zhang J; Liang C; Liao X; Liang R; Lin Y; Li Y Cancer Manag Res; 2018; 10():5759-5766. PubMed ID: 30532596 [TBL] [Abstract][Full Text] [Related]
18. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer. Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574 [TBL] [Abstract][Full Text] [Related]
19. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma. Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284 [TBL] [Abstract][Full Text] [Related]
20. Genomic instability-related twelve-microRNA signatures for predicting the prognosis of gastric cancer. Xu J; Song J; Chen X; Huang Y; You T; Zhu C; Shen X; Zhao Y Comput Biol Med; 2023 Mar; 155():106598. PubMed ID: 36764156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]